Pepgen announces ind-enabling preclinical data supporting progression of pgn-edodm1 into clinical studies

- pgn-edodm1 was well-tolerated in acute glp studies in rodents and non-human primates (nhps) at clinically relevant doses-
PEPG Ratings Summary
PEPG Quant Ranking